IL132516A - Pharmaceutical compositions of tizoxanide and nitazoxanide - Google Patents

Pharmaceutical compositions of tizoxanide and nitazoxanide

Info

Publication number
IL132516A
IL132516A IL13251698A IL13251698A IL132516A IL 132516 A IL132516 A IL 132516A IL 13251698 A IL13251698 A IL 13251698A IL 13251698 A IL13251698 A IL 13251698A IL 132516 A IL132516 A IL 132516A
Authority
IL
Israel
Prior art keywords
tizoxanide
nitazoxanide
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL13251698A
Other languages
English (en)
Other versions
IL132516A0 (en
Original Assignee
Romark Lab Lc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27420362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL132516(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/852,447 external-priority patent/US5968961A/en
Priority claimed from US08/887,809 external-priority patent/US5965590A/en
Priority claimed from US08/887,810 external-priority patent/US5856348A/en
Application filed by Romark Lab Lc filed Critical Romark Lab Lc
Priority to IL15579998A priority Critical patent/IL155799A/en
Publication of IL132516A0 publication Critical patent/IL132516A0/xx
Publication of IL132516A publication Critical patent/IL132516A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL13251698A 1997-05-07 1998-05-06 Pharmaceutical compositions of tizoxanide and nitazoxanide IL132516A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL15579998A IL155799A (en) 1997-05-07 1998-05-06 Pharmaceutical preparations of thizoxanide and nitazoxanide

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/852,447 US5968961A (en) 1997-05-07 1997-05-07 Pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,809 US5965590A (en) 1994-09-08 1997-07-03 Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,810 US5856348A (en) 1994-09-08 1997-07-03 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
PCT/US1998/009229 WO1998050035A1 (en) 1997-05-07 1998-05-06 Pharmaceutical compositions of tizoxanide and nitazoxanide

Publications (2)

Publication Number Publication Date
IL132516A0 IL132516A0 (en) 2001-03-19
IL132516A true IL132516A (en) 2003-12-10

Family

ID=27420362

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13251698A IL132516A (en) 1997-05-07 1998-05-06 Pharmaceutical compositions of tizoxanide and nitazoxanide
IL15579998A IL155799A (en) 1997-05-07 1998-05-06 Pharmaceutical preparations of thizoxanide and nitazoxanide

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL15579998A IL155799A (en) 1997-05-07 1998-05-06 Pharmaceutical preparations of thizoxanide and nitazoxanide

Country Status (35)

Country Link
EP (2) EP1005342B1 (sk)
JP (1) JP3739802B2 (sk)
KR (2) KR100576646B1 (sk)
CN (2) CN1158074C (sk)
AP (1) AP1103A (sk)
AR (1) AR057242A2 (sk)
AT (2) ATE228839T1 (sk)
AU (1) AU740022B2 (sk)
BG (2) BG109365A (sk)
BR (1) BR9808722A (sk)
CA (2) CA2418634C (sk)
CZ (2) CZ298270B6 (sk)
DE (2) DE69827417T2 (sk)
DK (2) DK1222921T3 (sk)
EA (2) EA002920B1 (sk)
EE (1) EE04870B1 (sk)
ES (2) ES2232687T3 (sk)
GE (1) GEP20032970B (sk)
HK (1) HK1025907A1 (sk)
HU (1) HU229641B1 (sk)
IL (2) IL132516A (sk)
IS (1) IS2087B (sk)
LV (1) LV12492B (sk)
ME (1) ME00530B (sk)
NO (2) NO313983B1 (sk)
NZ (2) NZ513881A (sk)
OA (1) OA11169A (sk)
PL (1) PL193275B1 (sk)
PT (2) PT1005342E (sk)
RO (1) RO120605B1 (sk)
SI (1) SI20149B (sk)
SK (2) SK283946B6 (sk)
TR (1) TR199902733T2 (sk)
UA (2) UA57079C2 (sk)
WO (1) WO1998050035A1 (sk)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
AU2007204963B2 (en) 2006-01-09 2012-09-27 Romark Laboratories, L.C. Viral hepatitis treatment
CA2752233C (en) * 2009-02-13 2017-01-03 Romark Laboratories L.C. Controlled release pharmaceutical formulations of nitazoxanide
CA2940954A1 (en) 2009-05-12 2010-11-18 Romark Laboratories L.C. Nitazoxanide and tizoxanide for the treatment of rhinovirus and rhabdovirus infections
ES2914949T3 (es) 2009-06-26 2022-06-17 Romark Laboratories Lc Compuestos y métodos para tratar la gripe
EP2808019B1 (en) 2012-01-27 2019-09-25 Siegfried Rhein S.A. De C.V. Improved nitazoxanide composition and preparation method thereof
TW201619142A (zh) * 2014-11-11 2016-06-01 羅馬克實驗室有限公司 利用替唑尼特（ｔｉｚｏｘａｎｉｄｅ）、其類似物或鹽類之前驅藥的組成物及治療方法
AU2019214347B2 (en) 2018-02-02 2023-09-28 Ripple Therapeutics Corporation Glass formulations comprising steroid dimers and uses thereof
CA3176134A1 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
WO2022130406A1 (en) * 2020-12-15 2022-06-23 Cipla Limited Inhalation composition of nitazoxanide or its derivatives for use in coronavirus disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives

Also Published As

Publication number Publication date
RO120605B1 (ro) 2006-05-30
CA2288003C (en) 2003-10-21
WO1998050035A1 (en) 1998-11-12
JP2001503067A (ja) 2001-03-06
HUP0003330A2 (hu) 2001-05-28
DK1005342T3 (da) 2003-03-24
CN1552322A (zh) 2004-12-08
DE69827417T2 (de) 2005-10-27
EA199901012A1 (ru) 2000-08-28
CN1255060A (zh) 2000-05-31
TR199902733T2 (xx) 2000-03-21
CA2418634A1 (en) 1998-11-12
AU740022B2 (en) 2001-10-25
KR20010020322A (ko) 2001-03-15
EP1005342A4 (en) 2001-02-07
EA002908B1 (ru) 2002-10-31
CZ298269B6 (cs) 2007-08-08
SI20149A (sl) 2000-08-31
NO995406D0 (no) 1999-11-04
DE69809928T2 (de) 2003-04-24
IS2087B (is) 2006-03-15
SK283947B6 (sk) 2004-05-04
EP1222921A1 (en) 2002-07-17
CZ298270B6 (cs) 2007-08-08
IL132516A0 (en) 2001-03-19
EA200100956A1 (ru) 2002-02-28
KR100576646B1 (ko) 2006-05-08
EE9900578A (et) 2000-08-15
NZ500149A (en) 2001-11-30
AU7289598A (en) 1998-11-27
ME00530B (me) 2011-10-10
PT1222921E (pt) 2005-02-28
BG109365A (en) 2006-08-31
HK1025907A1 (en) 2000-12-01
EE04870B1 (et) 2007-08-15
PL336805A1 (en) 2000-07-17
SK283946B6 (sk) 2004-05-04
PT1005342E (pt) 2003-02-28
DK1222921T3 (da) 2005-03-07
CN100515420C (zh) 2009-07-22
BG64973B1 (bg) 2006-11-30
NO335781B1 (no) 2015-02-16
DE69809928D1 (de) 2003-01-16
JP3739802B2 (ja) 2006-01-25
HUP0003330A3 (en) 2002-10-28
IS5223A (is) 1999-10-19
ES2232687T3 (es) 2005-06-01
KR20040004544A (ko) 2004-01-13
NO20021832D0 (no) 2002-04-18
ATE228839T1 (de) 2002-12-15
CA2288003A1 (en) 1998-11-12
LV12492B (en) 2001-01-20
SI20149B (en) 2001-08-31
AP1103A (en) 2002-09-04
HU229641B1 (en) 2014-03-28
EP1005342A1 (en) 2000-06-07
EP1005342B1 (en) 2002-12-04
OA11169A (en) 2003-04-25
AR057242A2 (es) 2007-11-21
BG103958A (en) 2000-07-31
ES2150404T3 (es) 2003-07-01
CZ391199A3 (cs) 2000-07-12
IL155799A (en) 2004-08-31
PL193275B1 (pl) 2007-01-31
UA57079C2 (uk) 2003-06-16
EA002920B1 (ru) 2002-10-31
DE69827417D1 (de) 2004-12-09
ATE281166T1 (de) 2004-11-15
NO313983B1 (no) 2003-01-13
CN1158074C (zh) 2004-07-21
GEP20032970B (en) 2003-05-27
IL155799A0 (en) 2003-12-23
KR100426657B1 (ko) 2004-04-13
NZ513881A (en) 2002-10-25
NO20021832L (no) 2000-01-04
LV12492A (en) 2000-06-20
ES2150404T1 (es) 2000-12-01
EP1222921B1 (en) 2004-11-03
AP9901675A0 (en) 1999-12-31
CA2418634C (en) 2004-10-26
BR9808722A (pt) 2000-07-11
SK151199A3 (en) 2000-07-11
UA74388C2 (uk) 2005-12-15
NO995406L (no) 2000-01-04

Similar Documents

Publication Publication Date Title
HUP0101999A3 (en) 4-hydroxyquinoline-3-carboxamides and hydrazides use of them and pharmaceutical compositions containing them
IL135589A0 (en) Aminothiazole derivatives and pharmaceutical compositions containing the same
HUP0003761A2 (en) Substituted alkanohydroxamic acids and pharmaceutical compositions containing them
HUP0103874A3 (en) Use of antibiotics and pharmaceutical compositions comprising thereof
HUP0001309A3 (en) 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
LT99141A (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
IL135646A0 (en) α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HUP0100149A3 (en) Antipicornaviral peptide derivatives pharmaceutical compositions comprising thereof and their use
HUP9902655A3 (en) Pharmaceutical composition of hedgehog proteins and use thereof
HUP9800147A3 (en) Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them
ZA984266B (en) Pharmaceutical composition and process of preparation
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
HUP0101701A3 (en) Substituted betha-alanines and pharmaceutical compositions comprising them
HUP0001858A3 (en) Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same and the use of the compounds
IL155799A0 (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
AU7681498A (en) Pharmaceutical composition and use thereof
HUP9900251A3 (en) Pharmaceutical compositions containing hedgehog proteins and use of former compositions
HUP0004274A3 (en) Bispyrido-cycloheptane compounds and pharmaceutical compositions thereof
AU6458898A (en) Compositions and use of m-csf-alpha
HUP0003827A3 (en) Cyanoamidine derivatives and pharmaceutical compositions containing them
GB9721071D0 (en) Pharmaceutical compositions and their use
HU9702369D0 (en) Pharmaceutical composition of natural active components
HUP9903370A3 (en) Beta-sulfonamido hydroxamic acids and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees